secwatch.observer — SEC 8-K summary
======================================

Issuer:     PepGen Inc. (PEPG)
CIK:        0001835597
Form:       8-K
Filed at:   2024-01-17T23:59:59+00:00
Accession:  0000950170-24-004824
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PepGen appoints Mary Beth DeLena as General Counsel and Secretary
-----------------------------------------------------------------

- Mary Beth DeLena joins PepGen as General Counsel and Secretary, effective January 17, 2024.
- She brings over 20 years of legal experience, most recently 15 years at Alnylam Pharmaceuticals as SVP, Deputy General Counsel.
- At Alnylam, she advised on strategic collaborations, licensing, and capital-raising through the company's transition to commercial stage.
- PepGen CEO cites her expertise in commercial, regulatory, and policy matters as key to advancing oligonucleotide therapies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835597/000095017024004824/0000950170-24-004824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835597/000095017024004824/pepg-20240117.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-004824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer